Bellerophon Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, BLPH, Bellerophon Therapeutics Inc, priceseries

Bellerophon Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
1.96
Close
1.93
High
2.07
Low
1.90
Previous Close
1.97
Daily Price Gain
-0.04
YTD High
3.40
YTD High Date
Jan 10, 2022
YTD Low
1.90
YTD Low Date
Mar 7, 2022
YTD Price Change
-1.28
YTD Gain
-39.88%
52 Week High
7.38
52 Week High Date
Mar 12, 2021
52 Week Low
1.90
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-4.22
52 Week Gain
-68.62%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 13. 2017
10.31
Jan 18. 2017
10.89
2 Trading Days
5.58%
Link
LONG
Feb 10. 2017
10.65
Mar 14. 2017
22.22
21 Trading Days
108.61%
Link
LONG
Sep 27. 2017
19.20
Oct 16. 2017
22.44
13 Trading Days
16.88%
Link
LONG
Nov 22. 2017
23.10
Dec 5. 2017
27.89
8 Trading Days
20.73%
Link
LONG
Dec 11. 2017
31.35
Dec 19. 2017
33.34
6 Trading Days
6.34%
Link
LONG
Mar 21. 2018
28.95
Mar 29. 2018
30.41
6 Trading Days
5.05%
Link
LONG
Jun 14. 2018
36.60
Jun 25. 2018
39.01
7 Trading Days
6.59%
Link
LONG
Sep 7. 2018
14.98
Sep 24. 2018
15.81
11 Trading Days
5.54%
Link
LONG
Nov 6. 2018
13.43
Nov 14. 2018
14.20
6 Trading Days
5.72%
Link
LONG
Nov 30. 2018
14.25
Dec 17. 2018
15.53
10 Trading Days
8.97%
Link
LONG
Jan 4. 2019
12.90
Jan 14. 2019
13.65
6 Trading Days
5.80%
Link
LONG
Mar 11. 2019
9.90
Mar 25. 2019
10.49
10 Trading Days
5.93%
Link
LONG
Oct 16. 2019
7.17
Oct 23. 2019
7.53
5 Trading Days
5.04%
Link
LONG
Dec 16. 2019
6.38
Dec 17. 2019
7.81
1 Trading Days
22.49%
Link
LONG
Feb 18. 2020
9.21
Feb 19. 2020
9.95
1 Trading Days
8.12%
Link
LONG
Feb 25. 2020
7.55
Feb 28. 2020
7.94
3 Trading Days
5.10%
Link
LONG
Mar 27. 2020
12.67
Mar 30. 2020
16.84
1 Trading Days
32.87%
Link
LONG
Apr 9. 2020
11.42
Apr 29. 2020
14.91
13 Trading Days
30.53%
Link
LONG
Jun 3. 2021
4.26
Jun 16. 2021
4.53
9 Trading Days
6.33%
Link
LONG
Dec 21. 2021
2.86
Dec 22. 2021
3.26
1 Trading Days
14.16%
Link
Company Information
Stock Symbol
BLPH
Exchange
NasdaqGM
Company URL
http://www.bellerophon.com
Company Phone
908-574-4770
CEO
Fabian Tenenbaum
Headquarters
New Jersey
Business Address
184 LIBERTY CORNER ROAD, SUITE 302, WARREN, NJ 07059
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001600132
About

Bellerophon Therapeutics, Inc. engages in developing products at the intersection of drugs and devices. Its products are using in the treatment of cardiopulmonary and cardiac diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.

Description

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates is INOpulse, a pulsatile nitric oxide delivery device, which is in Phase III clinical trials for the treatment of pulmonary arterial hypertension; and in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases and pulmonary hypertension associated with idiopathic pulmonary fibrosis. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading